Social Media Content Creators Fueling Parallel Market for Unlicensed Slimming Medication
A shadow market for unlicensed weight-loss medications is being driven by TikTok fitness influencers and vendors on communication apps, according to new investigations.
Experimental Treatment Acquiring Traction Online
The experimental drug, which remains in clinical trials, is being promoted by social media influencers for its alleged fat-burning properties. Viewers are encouraged to contact these profiles directly for source information, while also receiving promotional offers.
Active Commerce on Messaging Platforms
Additionally, a robust trade exists on Telegram, where communities with thousands of participants share “before and after” images, injection guides and claims of next-day British shipping. Sellers market the substance there before directing customers to WhatsApp for transactions.
Learning About The Experimental Drug
Retatrutide is an investigational injectable developed by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – GLP-1, GIP and glucagon. Preliminary studies indicate it could help individuals lose up to a quarter of their total weight. Referred to as the “triple G”, the substance is being promoted online as the next Ozempic.
Medical Professionals Voice Worries
However, physicians and chemists have cautions that the sale of what remains an unapproved medication in the UK is a cause for concern and could lead to individuals injecting products of uncertain source.
Some experts stated the popularity for retatrutide could be linked to the rising price of approved slimming treatments such as Mounjaro.
Regulatory Status and Enforcement
Selling the unapproved drug on social media or messaging apps is prohibited in the United Kingdom, as it is an unlicensed drug that cannot be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.
Some influencers try to circumvent the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but promotion and distribution can still violate medicines, marketing, and customer laws, risking penalties, legal action or imprisonment.
Platform Response and Content Elimination
According to TikTok, the service has taken down problematic material and prohibited associated hashtags and query recommendations. The organization stated it was committed to keeping the service secure and allocating resources in strengthening enforcement strategies.
Digital Trading Operations
Investigations also discovered groups with up to 9,000 participants marketing the experimental drug using Telegram's built-in search feature, which functions like a online catalog. Typing “retatrutide” immediately displays channels with thousands of users, filled with photos of slimming results, glowing reviews and detailed instructions for preparing or administering at residence.
After moments of joining one group, a vendor posted contact information, where most transactions occur. The seller provided an instruction manual and guaranteed shipping within two days. When questioned whether the substance was authentic, one seller responded: “You can’t be sure.” Another shared a image of a supposed testing documentation. None inquired about body mass, health issues or past usage.
Item Information and Pricing
Inside these communities, messages display dark colored packages with Royal Mail labels, claiming to contain fresh supplies. One message read: “It took eight of us to load them this morning.”
Customers can select between powder vials, prepared at residence with purified liquid, or ready-to-use injectors usually sold at £160 for 20 milligrams. When asked how long a pen should be used, sellers give contradictory responses ranging from a few weeks to “depends on your body”.
Service Oversight and Security Actions
A representative for Telegram said it actively moderated dangerous material on its service including material that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“People are injecting materials they can’t verify. Although the science behind this drug is valid, these online products may not contain what they advertise,” said Jason Murphy, the director of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor linked the increase in demand to recent cost increases for approved weight-loss medications such as Mounjaro. “With costs rising, patients are using social media. But counterfeit treatments are highly dangerous. You cannot know what’s inside or whether the conditions they were produced in was clean,” she explained.
Her staff has already encountered patients injured by self-injection from unconfirmed suppliers. “We understand the disappointment, but buying from Telegram or WhatsApp is taking chances with your health,” said the doctor. “These substances could be impure or improperly measured.”
Producer Statement
A spokesperson from Eli Lilly stated the substance was in third stage research studies and had not been evaluated or authorized by any government authority globally. “Consequently at this point no one can sell [it] for human use,” they explained, noting that any product “misleadingly claiming itself as a Lilly investigational product not yet authorized … may expose patients to possibly significant health risks”.
